WARSAW — Nextremity Solutions, a strategic commercialization organization with a focus on the musculoskeletal space, located in The Orthopedic Capital of the World in Warsaw, announced it has received 510(k) clearance by the Food and Drug Administration to market its upcoming InCore Lapidus System. “We’re excited about the 510(k) clearance of our InCore Lapidus System,” …read more.